Key Takeaways
- A new portable point‑of‑care PET system can image any organ in real time, offering high‑quality molecular imaging at the bedside.
- The technology combines a compact PET detector with a robotic arm that positions detector panels arbitrarily, enabling flexible, organ‑specific scans.
- Real‑time image updating (alternating single‑iteration reconstructions as new data arrive) yields image quality comparable to conventional full‑scan PET reconstruction, allowing early termination when diagnostic criteria are met.
- Phantom studies showed that structures become clearly distinguishable after only three to four detector positions, demonstrating the feasibility of abbreviated scanning protocols.
- The approach promises to bring the accuracy benefits of PET/CT‑guided interventions to hospitals that cannot afford dedicated hybrid systems, reducing cost and expanding access.
- Researchers are building a human‑compatible prototype, with initial clinical studies planned for 2027.
Introduction
Interventional radiology relies heavily on anatomical imaging modalities such as ultrasound, X‑ray fluoroscopy, and computed tomography (CT) to guide minimally invasive biopsies, tumor ablations, and vascular procedures. While these tools provide excellent spatial detail, they lack the molecular specificity that positron emission tomography (PET) can offer. Dedicated PET/CT systems have been shown to improve targeting accuracy and therapeutic outcomes, yet their high capital and operational costs limit widespread adoption, especially in smaller hospitals or resource‑constrained settings.
Technology Overview
To bridge this gap, a team at Washington University in St. Louis developed a portable point‑of‑care PET system featuring a lightweight detector panel mounted on a programmable robotic arm. The arm can reposition the detectors to arbitrary angles and distances, allowing the system to conform to the anatomy of virtually any organ or tissue region. Unlike conventional PET scanners that require a fixed gantry, this bedside device can be moved to the patient’s bedside, intensive care unit, or operating room, providing molecular imaging where it is needed most.
Experimental Design
The feasibility study employed a phantom containing three clusters of radiotracer‑filled rods to simulate heterogeneous tracer distribution. The portable PET detector panels were moved to six user‑selected positions around the phantom, acquiring data sequentially. Image reconstruction began with five iterations using data from the first position; thereafter, each newly acquired dataset triggered a single‑iteration update, alternating with data acquisition. Because data acquisition took considerably longer than reconstruction, images were continuously refreshed as new counts accumulated, mimicking a real‑time workflow. A conventional reconstruction method—where images are generated only after completing the full six‑position scan—was run in parallel for comparison.
Image Reconstruction Strategy
The real‑time updating framework leverages the fact that PET image quality improves incrementally with added counts. By performing a single iteration after each new position, the algorithm incorporates fresh information without waiting for the entire dataset, while still allowing the image to converge toward the final solution. This strategy supports interactive scanning: clinicians can observe evolving contrast and halt the acquisition once lesion delineation meets procedural requirements, thereby reducing scan time and patient discomfort.
Results and Image Quality
Reconstructed images from the real‑time updating approach were visually and quantitatively comparable to those produced by the conventional full‑scan method. Phantom structures—particularly the three rod clusters—became clearly distinguishable after only three to four detector positions, indicating that sufficient contrast‑to‑noise ratio for lesion detection could be achieved well before completing all six positions. Additional positions or further iterations continued to refine image sharpness and quantitative accuracy, demonstrating scalability of the method. These findings confirm that portable point‑of‑care PET can deliver diagnostic‑grade molecular images in a fraction of the time required by traditional scanners.
Implications for Interventional Radiology
The ability to obtain real‑time PET feedback at the bedside could transform image‑guided interventions. Clinicians could verify tracer uptake in target lesions before needle placement, monitor therapeutic response during ablation, or detect residual disease immediately after treatment—all without transporting the patient to a nuclear medicine suite. Because the portable system avoids the expense and infrastructure demands of a full PET/CT hybrid, it makes the accuracy advantages of PET‑guidance accessible to community hospitals, ambulatory surgery centers, and low‑resource settings.
Future Development and Human Trials
The current work utilized a benchtop prototype; the research team is now engineering a rugged, clinically portable version suitable for initial human imaging studies. Safety testing, regulatory compliance, and integration with existing interventional workflows are underway. The first in‑human trials are slated to begin in 2027, focusing on prostate and liver biopsies where PET‑guided targeting has demonstrated superior outcomes in hybrid‑scanner studies. Successful translation would validate the bedside PET concept and open avenues for novel molecular imaging applications, such as intraoperative immunotherapy monitoring or real‑time assessment of radiopharmaceutical biodistribution.
Conclusion
The portable point‑of‑care PET system represents a paradigm shift in molecular imaging accessibility. By combining a flexible robotic detector arrangement with real‑time iterative reconstruction, the technology delivers high‑quality PET images rapidly and affordably at the bedside. Phantom validation shows that diagnostic image clarity is achieved after only a few detector positions, enabling shortened scans and adaptive protocols. As the system moves toward human trials, it holds promise to enhance the precision, safety, and efficiency of interventional radiology procedures, ultimately extending the benefits of PET‑guided care to a broader patient population.